Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Betty, Njoroge"'
Autor:
Nelly R. Mugo, Victor Mudhune, Renee Heffron, Katherine K. Thomas, Eleanor McLellan-Lemal, Betty Njoroge, Sue Peacock, Siobhán M. O’Connor, Beatrice Nyagol, Eunice Ouma, Renee Ridzon, Jeffrey Wiener, Nina Isoherranen, David W. Erikson, Louise A. Ouattara, Nazita Yousefieh, Terry A. Jacot, Richard E. Haaland, Susan A. Morrison, Harald S. Haugen, Andrea R. Thurman, Shannon A. Allen, Jared M. Baeten, Taraz Samandari, Gustavo F. Doncel
Publikováno v:
Frontiers in Reproductive Health, Vol 5 (2023)
IntroductionGlobally, many young women face the overlapping burden of HIV infection and unintended pregnancy. Protection against both may benefit from safe and effective multipurpose prevention technologies.MethodsHealthy women ages 18–34 years, no
Externí odkaz:
https://doaj.org/article/5c0798227a72433685820cec538beb32
Autor:
Smritee Dabee, Nelly Mugo, Victor Mudhune, Eleanor McLellan-Lemal, Sue Peacock, Siobhan O’Connor, Betty Njoroge, Beatrice Nyagol, Andrea R. Thurman, Eunice Ouma, Renee Ridzon, Jeffrey Wiener, Harald S. Haugen, Melanie Gasper, Colin Feng, Shannon A. Allen, Gustavo F. Doncel, Heather B. Jaspan, Renee Heffron, Kisumu Combined Ring Study Team
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract In a phase-IIa trial, we investigated the influence of 90 days continuous-delivery tenofovir (TFV) intravaginal rings (IVRs) with/without levonorgestrel (LNG) on the genital microbiota of Kenyan women. Eligible women (n = 27; 18–34 years;
Externí odkaz:
https://doaj.org/article/68fd82a48b804787804310a51e78d2ca
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Deborah Donnell, Denise Galloway, Stephen Cherne, Kate Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, R. Scott McClelland, Jared M. Baeten, Connie Celum, Nelly Mugo, for the KEN SHE Study Team
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-19 (2021)
Abstract Background HPV infection is the primary cause of cervical cancer, a leading cause of cancer among women in Kenya and many sub-Saharan African countries. High coverage of HPV vaccination is a World Health Organization priority to eliminate ce
Externí odkaz:
https://doaj.org/article/b9ad1f12a24a46a89d5601c95e84f99c
Autor:
Matthew D Hickey, Gor B Ouma, Brian Mattah, Ben Pederson, Nicholas R DesLauriers, Pamela Mohamed, Joyce Obanda, Abdi Odhiambo, Betty Njoroge, Linda Otieno, Daniel E Zoughbie, Eric L Ding, Kathryn J Fiorella, Elizabeth A Bukusi, Craig R Cohen, Elvin H Geng, Charles R Salmen
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0255945 (2021)
BackgroundExisting social relationships are a potential source of "social capital" that can enhance support for sustained retention in HIV care. A previous pilot study of a social network-based 'microclinic' intervention, including group health educa
Externí odkaz:
https://doaj.org/article/20a62fb5aec5441ab8a6a11806554d8e
Autor:
Okeoma Mmeje, Betty Njoroge, Pauline Wekesa, Alfred Murage, Raphael O Ondondo, Sheryl van der Poel, Mary A Guzé, Starley B Shade, Elizabeth A Bukusi, Deborah Cohan, Craig R Cohen
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0212656 (2019)
BackgroundFemale positive/male negative HIV-serodiscordant couples express a desire for children and may engage in condomless sex to become pregnant. Current guidelines recommend antiretroviral treatment in HIV-serodiscordant couples, yet HIV RNA vir
Externí odkaz:
https://doaj.org/article/df2a02e9a57e46b1970eb690eeee0df5
Autor:
Ruanne V, Barnabas, Elizabeth R, Brown, Maricianah A, Onono, Elizabeth A, Bukusi, Betty, Njoroge, Rachel L, Winer, Denise A, Galloway, Leeya F, Pinder, Deborah, Donnell, Imelda, Wakhungu, Ouma, Congo, Charlene, Biwott, Syovata, Kimanthi, Linda, Oluoch, Kate B, Heller, Hannah, Leingang, Susan, Morrison, Elena, Rechkina, Stephen, Cherne, Torin T, Schaafsma, R Scott, McClelland, Connie, Celum, Jared M, Baeten, Nelly, Mugo
Publikováno v:
NEJM evidence. 1(5)
Single-dose HPV vaccination, if efficacious, would be tremendously advantageous; simplifying implementation and decreasing costs.We performed a randomized, multi-center, double-blind, controlled trial of single-dose nonavalent (HPV 16/18/31/33/45/52/
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Denise A. Galloway, Leeya F. Pinder, Deborah Donnell, Imelda Wakhungu, Ouma Congo, Charlene Biwott, Syovata Kimanthi, Lynda Oluoch, Kate B. Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, Stephen Cherne, Torin T. Schaafsma, R. Scott McClelland, Connie Celum, Jared M. Baeten, Nelly Mugo
Publikováno v:
NEJM Evidence. 1
Autor:
Smritee, Dabee, Nelly, Mugo, Victor, Mudhune, Eleanor, McLellan-Lemal, Sue, Peacock, Siobhan, O'Connor, Betty, Njoroge, Beatrice, Nyagol, Andrea R, Thurman, Eunice, Ouma, Renee, Ridzon, Jeffrey, Wiener, Harald S, Haugen, Melanie, Gasper, Colin, Feng, Shannon A, Allen, Gustavo F, Doncel, Heather B, Jaspan, Renee, Heffron, Deborah, Donnell
Publikováno v:
Scientific reports. 12(1)
In a phase-IIa trial, we investigated the influence of 90 days continuous-delivery tenofovir (TFV) intravaginal rings (IVRs) with/without levonorgestrel (LNG) on the genital microbiota of Kenyan women. Eligible women (n = 27; 18-34 years; negative fo
Autor:
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah A. Onono, Elizabeth A. Bukusi, Betty Njoroge, Rachel L. Winer, Denise A. Galloway, Leeya F. Pinder, Deborah Donnell, Imelda Wakhungu, Ouma Congo, Charlene Biwott, Syovata Kimanthi, Lynda Oluoch, Kate B. Heller, Hannah Leingang, Susan Morrison, Elena Rechkina, Stephen Cherne, Torin T. Schaafsma, R. Scott McClelland, Connie Celum, Jared M. Baeten, Nelly Mugo, for the KEN SHE Study Team
Background: Single-dose HPV vaccination, if efficacious, would be tremendously advantageous; simplifying implementation and decreasing costs.Methods: We performed a randomized, multi-center, double-blind, controlled trial of single-dose nonavalent (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::338944cd34fb28160ff019530752cf0a
https://doi.org/10.21203/rs.3.rs-1090565/v1
https://doi.org/10.21203/rs.3.rs-1090565/v1
Autor:
Elizabeth A. Bukusi, Nelly Mugo, Kate B. Heller, Connie Celum, Rachel L. Winer, Denise A. Galloway, Hannah Leingang, Betty Njoroge, Ruanne V. Barnabas, Jared M. Baeten, Deborah Donnell, Elizabeth R. Brown, Maricianah Onono, Stephen L. Cherne, Elena Rechkina, R. Scott McClelland, Susan Morrison
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-19 (2021)
Trials
Trials
Background HPV infection is the primary cause of cervical cancer, a leading cause of cancer among women in Kenya and many sub-Saharan African countries. High coverage of HPV vaccination is a World Health Organization priority to eliminate cervical ca